GP-TCM consortium represents experts and innovators in the fields of TCM and functional genomics research. Although not all partners have worked together before, the consortium aims to strengthen new collaborations between all contributing partners from EU and Non-EU countries. Each partner brings particular expertise to the consortium as well as gaining an opportunity to forge new alliances. Every partner represents an organisation that specialises in either TCM research or functional genomics research or both, and therefore, has a focus clearly on coordinating and improving the studies of TCM using the functional genomics strategy. A broad range of organisation types are participating in this project. We feel this is a particular strength, as the potential for sharing and learning from each other’s expertise is maximised. The consortium is bringing together not only academic universities and institutes, but also clinical centres of complementary medicines, TCM clinics, pan-European suppliers of Chinese medicines, and SMEs in TCM and microarray industries. We feel the mix of organisation types, which are involved in varying combinations within work packages, will offer excellent learning opportunities to strengthen future collaboration. The professional mix will also enhance the utility and feasibility of our recommendations for best practice and measurement through the combination of professional perspectives.

The consortium has 29 beneficiary (i.e. funded) partner organisations across 10 EU member states (Austria, Belgium, Estonia, Germany, Ireland, Italy, the Netherlands, Portugal, Spain and UK) and China, which is an International Cooperation Partner Country (ICPC) of the EU. The consortium has additional 80 non-beneficiary (i.e. unfunded) collaborating partner organisations as well as 2 independent experts from Australia, Austria, Belgium, Burkina Faso, Canada, China, D.R. Congo, Denmark, Finland, Germany, Italy, Luxembourg, the Netherlands, Norway, Romania, Russia, Spain, Sweden, Thailand, UK and USA.
Beneficiary Partners:
GP-TCM beneficiary partners Country
King’s College London UK
University of Vienna Austria
L’Université Libre de Bruxelles Belgium
Beijing University of Chinese Medicine China
China Capital Medical University China
Institute of Medicinal Plant Development China
Shanghai Institute of Acupuncture-Moxibustion China
Shanghai University of Traditional Chinese Medicine China
University of Hong Kong China
Asper Biotech Ltd Estonia
Federal Institute for Drugs and Medical Devices Germany
University of Düsseldorf Germany
University of Munich Germany
University of Bonn Germany
Trinity College Dublin Ireland
University of Milan Italy
University of Padova Italy
CMC Tasly Group BV The Netherlands
Leiden University The Netherlands
University of Minho Portugal
University of Alcala Spain
University Hospital Ramón y Cajal-FIBIO Spain
Acu-herb Consultant, Sheffield UK
University of Wolverhampton UK
Royal Botanic Gardens, Kew UK
University of Southampton UK
University of Cambridge UK
Brunel University UK
London South Bank University UK
Non-Beneficiary Partners:
GP-TCM Non-beneficiary partners Country
University of Western Sydney Australia
University of Graz Austria
Medical University of Graz Austria
University of Mons Belgium
University of Ouagadougou Burkina Faso
University of British Columbia Canada
Beijing East Linden Science and Technology Co. Ltd. China
Chengdu University of Traditional Chinese Medicine China
China Academy of Chinese Medical Sciences China
China-Japan Friendship Hospital China
Dalian Institute of Chemical Physics China
Hong Kong Baptist University China
Jinan University China
Peking University China
PuraPharm China
Shanghai Innovation Research Centre of Traditional Medicine China
Shanghai Jiaotong University China
Shanghai Institute of Materia Medica, Chinese Academy of Sciences China
Tongji University China
Tasly Institute of Tasly Group Co., Ltd. China
Tianjin University of Traditional Chinese Medicine China
University of Macau China
The Chinese University of Hong Kong China
Pfizer Corporation Hong Kong Ltd China
State Food and Drug Administration China
National Research Institute of Chinese Medicine, Taiwan China
Hospital Authority of Hong Kong China
Zhejiang Gongshang University China
Zhejiang University China
Second Military Medical University China
Yanbian University of Science and Technology China
University of Lubumbashi Congo
University of Aarhus Denmark
University of Oulu Finland
Charité University Medical Center Germany
Johannes Gutenberg University Germany
University of Regensburg Germany
Philipps – Universität Marburg Germany
Max Planck Institute for Biophysics Germany
Universität Münster Germany
Dr Willmar Schwabe GmbH & Co. KG Germany
Caesar & Loretz GmbH Germany
Heidelberg School of Chinese Medicine Germany
Merck Selbstmedikation GmbH Germany
University of Mainz Germany
Wei Medicine Germany
Universität Leipzig Germany
HanseMerkur Center for TCM at the University Medical Center Hamburg Eppendorf Germany
University of Cagliari Italy
University of Rome Tor Vergata Italy
Institute of Neurobiology and Molecular Medicine, Italian National Research Council Italy
Public Research Centre of Health Luxembourg
SU BioMedicine The Netherlands
Norwegian University of Science and Technology Norway
Transylvanian Association of Integrated Quantum Medicine Romania
St-Petersburg Institute of Pharmacy Russia
Biothani Europe S.L. Spain
University of Gothenburg Sweden
Thailand Ministry of Public Health Thailand
School of Pharmacy UK
University of Reading UK
Guy’s & St Thomas’ NHS Foundation Trust UK
University of Nottingham UK
University of Warwick UK
University of Westminster UK
University of Lincoln UK
University of the West England UK
Imperial College London UK
Global Regulatory Services UK
Link China Pharma Solutions UK
University of Oxford UK
University of East London UK
Pharsafer Associates Limited UK
Avicenna UK
British Acupuncture Council UK
University College London UK
University of Louisville USA
Yale University USA
U.S. Food and Drug Administration USA
Vanderbilt University Medical Center USA
Independent UK
Independent UK
Advising Bodies:
  • European Commission, EU
  • Ministry of Science & Technology, China